Georgia Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Georgia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions for the use and commercialization of intellectual property developed by the University. This agreement grants Gentling, Inc. a license to certain technologies, patents, trademarks, copyrights, and other intellectual property owned by the University, with the purpose of further development and commercialization. The Georgia Collateral License Agreement enables Gentling, Inc. to utilize the University's scientific research, technology, and expertise in a collaborative effort to advance medical, pharmaceutical, and biotechnological innovations. Under this agreement, Gentling, Inc. gains the exclusive or non-exclusive rights to develop, manufacture, market, and sell products or services based on the licensed intellectual property. The agreement also includes provisions related to the protection of intellectual property rights, confidentiality, sublicensing, royalties, and reporting obligations. Both parties have responsibilities and obligations regarding the diligence, financial and legal commitments, and maintaining the highest standards of scientific integrity and ethics. Different types of Georgia Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center might include: 1. Exclusive License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use and exploit the licensed intellectual property within a specific field or industry. This means that no other entity, except the University, can operate in the same market niche. 2. Non-Exclusive License Agreement: This type of agreement grants Gentling, Inc. non-exclusive rights to use and exploit the licensed intellectual property. Multiple entities can obtain similar licenses, allowing for broader innovation and market competition. 3. Field-Specific License Agreement: This agreement gives Gentling, Inc. rights to use and exploit the licensed intellectual property specifically within a defined field, such as medicine, biotechnology, or pharmaceuticals. 4. Territory-Specific License Agreement: This type of agreement grants Gentling, Inc. rights to use and exploit the licensed intellectual property within a specific geographical territory, such as the state of Georgia or certain counties. In summary, the Georgia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document that governs the utilization, development, and commercialization of intellectual property for the advancement of medical and scientific innovations. The specific terms and types of agreements vary based on the nature of the licensed intellectual property and the intentions of the parties involved.

Georgia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions for the use and commercialization of intellectual property developed by the University. This agreement grants Gentling, Inc. a license to certain technologies, patents, trademarks, copyrights, and other intellectual property owned by the University, with the purpose of further development and commercialization. The Georgia Collateral License Agreement enables Gentling, Inc. to utilize the University's scientific research, technology, and expertise in a collaborative effort to advance medical, pharmaceutical, and biotechnological innovations. Under this agreement, Gentling, Inc. gains the exclusive or non-exclusive rights to develop, manufacture, market, and sell products or services based on the licensed intellectual property. The agreement also includes provisions related to the protection of intellectual property rights, confidentiality, sublicensing, royalties, and reporting obligations. Both parties have responsibilities and obligations regarding the diligence, financial and legal commitments, and maintaining the highest standards of scientific integrity and ethics. Different types of Georgia Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center might include: 1. Exclusive License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use and exploit the licensed intellectual property within a specific field or industry. This means that no other entity, except the University, can operate in the same market niche. 2. Non-Exclusive License Agreement: This type of agreement grants Gentling, Inc. non-exclusive rights to use and exploit the licensed intellectual property. Multiple entities can obtain similar licenses, allowing for broader innovation and market competition. 3. Field-Specific License Agreement: This agreement gives Gentling, Inc. rights to use and exploit the licensed intellectual property specifically within a defined field, such as medicine, biotechnology, or pharmaceuticals. 4. Territory-Specific License Agreement: This type of agreement grants Gentling, Inc. rights to use and exploit the licensed intellectual property within a specific geographical territory, such as the state of Georgia or certain counties. In summary, the Georgia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document that governs the utilization, development, and commercialization of intellectual property for the advancement of medical and scientific innovations. The specific terms and types of agreements vary based on the nature of the licensed intellectual property and the intentions of the parties involved.